We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5711:TSEMitsubishi Materials Corp. Analysis

Data as of 2026-03-11 - not real-time

¥5,260.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technically, Mitsubishi Materials trades at 5,260 JPY, just below its 20‑day SMA (5,342 JPY) but comfortably above the 50‑day and 200‑day averages, indicating a lingering bullish bias. The RSI sits at 53, suggesting neutral momentum, while the MACD histogram is negative, signaling short‑term bearish pressure. Volume remains stable and the price is anchored above the identified support at 4,662 JPY, with a sizable upside ceiling near the 61‑26‑week high of 6,126 JPY. Market sentiment is exuberant, reflected by a Fear & Greed Index of 75.48 (“Extreme Greed”), yet the 30‑day volatility of roughly 69% warns of sizable price swings.
Fundamentally, the company posts modest profitability (gross margin 9.2%, operating margin 3.6%) and a low ROE of 3.8%, while revenue is contracting (-8%). The trailing PE of 46 is high, but the forward PE of 15.6 and a forward EPS outlook of 336.13 JPY point to earnings acceleration. A price‑to‑book ratio below 1 (0.96) hints at relative undervaluation, though the debt‑to‑equity ratio of 93 is a red flag, and a payout ratio near 88% raises questions about dividend sustainability despite a 1.94% yield.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram suggests limited upside in the near term
  • High trailing PE indicates current price may be stretched
  • Stable volume and support level provide downside protection

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS growth and forward PE of 15.6 imply earnings upside
  • Price‑to‑book below 1 signals relative undervaluation
  • Bullish trend direction and strong market sentiment support upside potential

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio and low ROE pose structural profitability concerns
  • Diversified global footprint mitigates geographic concentration risk
  • Dividend payout near 88% may become unsustainable without cash‑flow improvement

Key Metrics & Analysis

Financial Health

Revenue Growth-8.00%
Profit Margin1.21%
P/E Ratio46.1
ROE3.82%
ROA0.69%
Debt/Equity92.90
P/B Ratio1.0

Technical Analysis

TrendBullish
RSI53.3
Support¥4,662.00
Resistance¥6,126.00
MA 20¥5,341.95
MA 50¥4,669.62
MA 200¥3,150.32
MACDBearish
VolumeStable
Fear & Greed Index75.48

Valuation

Target Price¥4,484.29
Upside/Downside-14.75%
GradeFair
TypeBlend
Dividend Yield1.94%

Risk Assessment

Beta0.59
Volatility69.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.